Education Library

Prof. Evgenij Potapov explains how “ECpella 2+” achieves over 50% survival in patients with very severe cardiogenic shock while minimizing complications and enabling mobilization.

Prof. Evgenij Potapov discusses improved survival in patients who were treated at his institution with standard operating procedures (SOPs) for cardiogenic shock.

Alan Gass, MD, discusses data from successful management of patients with Impella 5.5® with SmartAssist® heart pump and ECMO.

Roberto Lorusso, MD, Alan Gass, MD, and Evgenij Potapov, MD, discuss topics related to ECpella and LV unloading in this Q&A session from ELSO 2022.

Prof. Jan Belohlavek, MD, discusses ECMO CS trial results comparing immediate VA ECMO with conservative therapy allowing VA ECMO downstream in severe cardiogenic shock.

This article presents 3 case vignettes that provide practical insights and reinforce best practices. The authors emphasize that several cardiac and patient-related factors come into play when considering patients for Protected percutaneous coronary intervention (PCI).

In this article the authors describe techniques for Impella heart pump removal with or without pre-closure and discuss how to prevent and manage complications associated with large-bore femoral access.

This article describes how the interventional cardiology team handles high-risk patients in the cath lab, from procedural preparation and planning through procedural monitoring, as well as weaning strategies and access site management.

This article explores optimal revascularization strategies for patients undergoing Protected PCI.

This article describes pre-procedural preparation, with a particular focus on imaging techniques for screening and guiding vascular access in patients undergoing Protected PCI.

Patients undergoing elective high-risk PCI are often in critical condition and not candidates for coronary artery bypass graft (CABG) surgery.

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS)during high risk intervention, highlighting the following topics...

Prof. Dr. Nikos Werner introduces European best practices for optimizing Protected PCI with Impella heart pumps that were recently published in European Heart Journal Supplements.

Francesco Burzotta, MD, discusses the use of percutaneous mechanical circulatory support (pMCS) strategies in both high-risk PCI and cardiogenic shock.

Dr. Pal Soos interviews Prof. Dr. Christophe Vandenbriele, a cardiologist and intensivist from UZ Leuven (Belgium) and research fellow at Royal Brompton Hospital in London. Dr.